HW

Hexiang Wang

BE Beigene: 14 patents #3 of 41Top 8%
Overall (All Time): #344,359 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11472788 Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases Yunhang Guo, Zhiwei Wang, Changyou Zhou 2022-10-18
11202782 Treatment cancers using a combination comprising PARP inhibitors Lai-Xi Wang, Zhiyu Tang, Lusong Luo, Min Wei, Kang Li +4 more 2021-12-21
10899763 Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof Xianzhao Kuang, Changyou Zhou 2021-01-26
10882856 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases Yunhang Guo, Bo Ren, Zhiwei Wang, Guoliang Zhang, Changyou Zhou 2021-01-05
10647714 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases Guoliang Zhang, Yunhang Guo, Bo Ren, Zhiwei Wang, Changyou Zhou 2020-05-12
10501467 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2019-12-10
10457680 Process for preparing a PARP inhibitor, crystalline forms, and uses thereof Changyou Zhou, Bo Ren, Xianzhao Kuang 2019-10-29
10280163 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases Guoliang Zhang, Yunhang Guo, Bo Ren, Zhiwei Wang, Changyou Zhou 2019-05-07
10112952 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2018-10-30
9827226 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones Bo Ren, Changyou Zhou 2017-11-28
9617273 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2017-04-11
9393232 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones Bo Ren, Changyou Zhou 2016-07-19
9328111 Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors Changyou Zhou, Bo Ren 2016-05-03
9260440 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2016-02-16